Adams v. American Medical System, Inc.

705 F. App'x 744
CourtCourt of Appeals for the Tenth Circuit
DecidedAugust 25, 2017
Docket14-4057
StatusUnpublished
Cited by4 cases

This text of 705 F. App'x 744 (Adams v. American Medical System, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adams v. American Medical System, Inc., 705 F. App'x 744 (10th Cir. 2017).

Opinion

*745 ORDER AND JUDGMENT *

David M. Ebel Circuit Judge

In this product liability case governed by Utah law, Plaintiff-Appellant Gerry Adams alleged that a mesh sling that she had surgically implanted to treat stress urinary incontinence was defective. The question presented in this appeal is whether Adams’s product liability claims are barred by the applicable statute of limitations. That statute required Adams to bring her claims within two years after she discovered, or in the exercise of due diligence should have discovered, her “harm and its cause.” Utah Code § 78B-6-706. We conclude that Adams knew, or should have known, by November 2007—when she was told she had to undergo a second operation to remove part of the mesh sling in order to remedy severe pain and bleeding—that she had been harmed by the sling. Because Adams did not assert her product liability claims until five and one-half years later, those claims are now time-barred. Therefore, having jurisdiction under 28 U.S.C. § 1291, we AFFIRM the district court’s decision to dismiss Adams’s claims under Fed. R. Civ. P. 12(b)(6).

I. BACKGROUND

In reviewing the district court’s Rule 12(b)(6) dismissal of Adams’s claims, we accept her well-pled factual allegations as true and construe those facts in the light most favorable to her, see Pace v. Swerdlow, 519 F.3d 1067, 1073 (10th Cir. 2008); we also consider the medical records that Adams attached to her amended complaint, see Free Speech v. Fed. Election Comm’n, 720 F.3d 788, 792 (10th Cir. 2013). Doing so, the record before us indicates the following: Defendants American Medical System, Inc. and Caldera Medical, Inc. “manufactured, designed, and distributed the Desara Sling System.” (J.A. at 27 ¶ 15.) In July 2007, doctors surgically implanted a Desara mesh sling into Adams’s pelvic area in order to treat her stress urinary incontinence.

Several months after this surgery, Adams complained of severe pain and vaginal bleeding. In November 2007, one of her doctors discovered that a portion of the sling had migrated and was “protruding into the vaginal canal” and “needled] to be excised” “as much as possible.” (Id. at 59.) One month later, in December 2007, Adams underwent a second surgery during which her surgeon excised “nearly 2 cm of the” mesh sling. (Id. at 33 ¶ 57.) After that second surgery, Adams’s stress incontinence was “worse than before” the sling was implanted (id. at 34 ¶ 58), and “[s]he continued to suffer severe complications from the” sling (id. ¶ 60), including “vaginal pain, vaginal bleeding, painful intercourse, incontinence and severe infections” occurring “every couple of months” (id. at 33 ¶ 54; 72). In February 2013, Adams saw a new doctor, who discovered “two pieces of mesh protruding through [Adams’s] vaginal roof’ (id. at 71), and recommended that the sling “be completely removed, because it continues to migrate from its place of implantation, is harboring infections, and is adversely affecting Ms. Adams’s health and comfort” (id. at 34 ¶ 64).

Adams initiated this litigation in June 2013, which was soon after her new doctor’s recommendation that the entire sling be removed, but six years after the mesh sling was surgically implanted and five and one-half years after the second surgery, in December 2007, to excise a portion of the sling. The district court granted Defen *746 dants’ Rule 12(b)(6) motions to dismiss, ruling that Adams’s claims were barred by-Utah’s two-year statute of limitations for product liability claims. Adams appeals that decision. 2 While this appeal was pending, Adams and Caldera settled her claim against it, and at the request of those two parties, Caldera has now been dismissed from this appeal with prejudice. In light of that, American Medical System remains as the only appellee. 3

II. STANDARD OF REVIEW

We review the district court’s Rule 12(b)(6) decision de novo. See Pace, 519 F.3d at 1073. In this diversity case, the parties agree that Utah substantive law governs. “As a federal court sitting in diversity, [then,] our task is simply to ascertain and apply [Utah] law, attempting to predict what the state’s highest court would do if faced with the specific issues before us on appeal.” Flores v. Monumental Life Ins. Co., 620 F.3d 1248, 1250 (10th Cir. 2010) (internal quotation marks omitted).

III. DISCUSSION

The parties agree that the statute of limitations that applies to Adams’s claims is Utah Code § 78B-6-706, which provides that “[a] civil action under [Utah’s Product Liability Act] shall be brought within two years from the time the individual who would be the claimant in the action discovered, or in the exercise of due diligence should have discovered, both the harm and its cause.” (Emphasis added.) See generally Elm Ridge Expl. Co. v. Engle, 721 F.3d 1199, 1210 (10th Cir. 2013) (applying state statute of limitation in diversity action). Because § 78B-6-706 requires a plaintiff to exercise due diligence in discovering the harm and its cause, “all that is required to start the running of the limitation period is information sufficient to put the plaintiff on notice to make further inquiry.” Griffiths-Rast v. Sulzer Spine Tech, 216 Fed.Appx. 790, 795 (10th Cir. 2007) (unpublished) (quoting Macris v. Sculptured Software, Inc., 422 Utah Adv. Rep. 6, 24 P.3d 984, 990 (2001), and applying Utah Code § 78-15-3, the predecessor to § 78B-6-706); see also Ziots v. Stryker Corp., 655 Fed.Appx. 622, 625 (10th Cir. 2016) (unpublished). 4 The assertion that a claim is barred by the relevant statute of limitations is an affirmative defense, which the defendant bears the burden of proving. See Utah R. Civ. P. 8(c), 9(h). See generally Cahill v. Am. Family Mut. Ins. Co., 610 F.3d 1235, 1238 (10th Cir. 2010) (applying state burden of proof to issues underlying statute-of-limitations defense).

A. Adams discovered that she had been harmed no later than November 2007

Section 78B-6-706’s two-year limitations period did not begin'to run until Adams discovered, or in the exercise of due diligence should have discovered, that she had been harmed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
705 F. App'x 744, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adams-v-american-medical-system-inc-ca10-2017.